ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ErbB2 signaling epigenetically suppresses microRNA-205 transcription via Ras/Raf/MEK/ERK pathway in breast cancer
Authors
Keywords
-
Journal
FEBS Open Bio
Volume 7, Issue 8, Pages 1154-1165
Publisher
Wiley
Online
2017-06-12
DOI
10.1002/2211-5463.12256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer
- (2016) Callie R. Merry et al. Oncotarget
- Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
- (2016) Debora de Melo Gagliato et al. Oncotarget
- Involvement of MicroRNA-210 Demethylation in Steroid-associated Osteonecrosis of the Femoral Head
- (2016) Heng-feng Yuan et al. Scientific Reports
- DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer
- (2016) Haixin Yin et al. Scientific Reports
- International Variation in Female Breast Cancer Incidence and Mortality Rates
- (2015) C. E. DeSantis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer
- (2015) Takeshi Yamaguchi et al. ONCOLOGY
- Original paper Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting
- (2015) Agnieszka Adamczyk et al. POLISH JOURNAL OF PATHOLOGY
- Hepatitis B Virus X Protein Inhibits Tumor Suppressor miR-205 through Inducing Hypermethylation of miR-205 Promoter to Enhance Carcinogenesis
- (2015) Tao Zhang et al. NEOPLASIA
- microRNA-34b/con chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia
- (2014) Stefan Deneberg et al. Epigenetics
- Whole genome DNA methylation signature of HER2-positive breast cancer
- (2014) Breezy M Lindqvist et al. Epigenetics
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation
- (2014) Bo-Kuan Wu et al. Cell Reports
- A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype
- (2014) Ryan W Serra et al. eLife
- A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells
- (2013) Daya Luo et al. Journal of Translational Medicine
- Loss of the polycomb protein Mel-18 enhances the epithelial–mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer
- (2013) J-Y Lee et al. ONCOGENE
- PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1
- (2013) H. Ebi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-205 regulates basement membrane deposition in human prostate: implications for cancer development
- (2012) P Gandellini et al. CELL DEATH AND DIFFERENTIATION
- HER2-specific T lymphocytes kill both trastuzumab-resistant and trastuzumab-sensitive breast cell lines in vitro
- (2012) Xiao-lin Lin et al. Chinese Journal of Cancer Research
- Prevalence of Breast Cancer Risk Factors in Japan
- (2012) Y. Mizota et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The p63 Protein Isoform ΔNp63α Inhibits Epithelial-Mesenchymal Transition in Human Bladder Cancer Cells
- (2012) Mai N. Tran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
- (2012) Joong Sup Shim et al. JNCI-Journal of the National Cancer Institute
- Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer
- (2012) T Hulf et al. ONCOGENE
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- ErbB2 down-regulates microRNA-205 in breast cancer
- (2011) Ryohei Adachi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
- (2011) B Weigelt et al. ONCOGENE
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer
- (2010) Erik D. Wiklund et al. INTERNATIONAL JOURNAL OF CANCER
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
- (2010) N Bhatnagar et al. Cell Death & Disease
- Association between frequent CpG island methylation and HER2 amplification in human breast cancers
- (2009) Kotoe Terada et al. CARCINOGENESIS
- Suppression of cell growth and invasion by miR-205 in breast cancer
- (2009) Hailong Wu et al. CELL RESEARCH
- Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data
- (2009) David L. Corcoran et al. PLoS One
- Ras regulation of DNA-methylation and cancer
- (2008) Samir Kumar Patra EXPERIMENTAL CELL RESEARCH
- Chromatin structure analyses identify miRNA promoters
- (2008) F. Ozsolak et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started